Cullinan Therapeutics (CGEM) Treasury Shares (2023 - 2025)

Cullinan Therapeutics' Treasury Shares history runs 5 years deep, the most recent figure standing at $85.6 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 6499.85% year-over-year to $85.6 million; the TTM figure through Dec 2025 stood at $85.6 million (up 6499.85% YoY), while the FY2025 annual figure was $85.6 million, up 6499.85% from the prior year.
• Treasury Shares for Q4 2025 stood at $85.6 million, roughly flat from $85.6 million in the prior quarter.
• The five-year high for Treasury Shares was $85.6 million in Q2 2023, with the low at $15.0 in Q4 2022.
• The 4-year median for Treasury Shares is $85.6 million (2023), against an average of $64.4 million.
• The sharpest annual moves came in 2023 and 2024: Treasury Shares soared 5359900.0% in 2023, then changed 0.0% in 2024.
• Cullinan Therapeutics' Treasury Shares stood at $15.0 in 2022, then jumped by 5359900.0% to $804000.0 in 2023, then jumped by 61.32% to $1.3 million in 2024, then jumped by 6499.85% to $85.6 million in 2025.
• Business Quant data shows CGEM's Treasury Shares at $85.6 million in Q4 2025, $85.6 million in Q3 2025, and $85.6 million in Q2 2025.